Skip to content
Screener

Twist Bioscience Corporation TWST Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Azenta logo
AzentaAZTA
$277.52M
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$32.79M-35.5%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$19.96M
Agilent Technologies logo
Agilent TechnologiesA
Illumina logo
IlluminaILMN
GeneDx Holdings logo
GeneDx HoldingsWGS

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$7.25B+335%
Enterprise value$7.24B+365%
P/S17.7×+13.1×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(in thousands, except for years)March 31, 2026 / Weighted average Amortization periodin yearsMarch 31, 2026 / GrosscarryingamountMarch 31, 2026 / AccumulatedamortizationNet bookvalue
Developed Technology17$18,000$(5,004)$12,996
Total finite-lived intangible assets$18,000$(5,004)$12,996

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's finite-lived intangible assets, accumulated amortization?
Twist Bioscience Corporation (TWST) reported finite-lived intangible assets, accumulated amortization of $5M in Q1 2026.
How has Twist Bioscience Corporation's finite-lived intangible assets, accumulated amortization changed year-over-year?
Twist Bioscience Corporation's finite-lived intangible assets, accumulated amortization decreased by 3.2% year-over-year, from $5.17M to $5M.
What is the long-term trend for Twist Bioscience Corporation's finite-lived intangible assets, accumulated amortization?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's finite-lived intangible assets, accumulated amortization has grown at a 34.5% compound annual growth rate (CAGR), from $1.37M to $4.48M.

Ask your AI about Twist Bioscience Corporation's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude